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Time-dependent changes in inner medullary plasma flow rate
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LINDA N. PETERSON
Departments of Pediatrics and Physiology, University of Ottawa, Ottawa, Ontario, Canada
Time-dependent changes in inner medullary plasma flow during potas-
sium-depletion. Renal concentrating ability becomes impaired after
approximately 2 weeks of dietary potassium (K) depletion in the rat.
Since inner medullary plasma flow (IMPF) has been shown to be
reduced after 3 weeks of K-depletion, IMPF was measured after 2 and 3
weeks of dietary K-deprivation to determine if the change in IMPF is
present at the time the renal concentrating defect first appears. In the
present study, similar reductions in maximal urine concentration were
present in rats K-depleted for 2 and 3 weeks. IMPF measured by the
1251 albumin accumulation method, however, was normal after 2 weeks
of K-depletion (control, 35.1 1.93 vs. K-depletion 2 weeks, 32.8
1.52 mI/min/IQO g IM), and was reduced after 3 weeks of this dietary
regime (K-depletion, 3 weeks: 13.8 1.84). To determine the mecha-
nism of the decrease in IMPF after 3 weeks of K-depletion, rats were
treated acutely with indomethacin. There was no significant change in
IMPF in control or 3-week K-depleted rats following treatment with
indomethacin. These results suggest that the reduction in medullary
solute content after 2 weeks of K-depletion cannot be attributed to a
reduction in IMPF. In addition, products of the cyclooxygenase en-
zyme systems do not appear to contribute in a major way to the
reduction in IMPF measured after 3 weeks of dietary K-depletion.
Modifications dépendantes du temps du debit plasmatique médullaire
interne lors de Ia depletion en potassium. Le pouvoir de concentration du
rein s'aitére après environ 2 semaines de depletion alimentaire en
potassium (K) chez le rat. Puisqu'il a été montré que le debit plasmati-
que médullaire interne (IMPF) est rCduit aprés 3 semaines de déplétion
en K, IMPF a été mesurC après 2 et 3 semaines de restriction
alimentaire en K afin de determiner si Ia modification d'IMPF existe au
moment ou le trouble de concentration rénale apparait pour Ia premiere
fois. Dans cette étude, des reductions identiques de Ia concentration
urinaire maximale étaient présentes chez des rats deplétés en K depuis
2 et 3 semaines. Cependant, IMPF mesuré par Ia méthode de l'accumu-
iation de '251-albumine était normal après 2 semaines de depletion en K
(contrôle, 35,1 1,93 contre déplétion en K 2 semaines, 32,8 1,52
mL/min/lOO g IM) et était réduit aprês 3 semaines de cc régime
alimentaire (depletion en K, 3 semaines: 13,8 1,84). Afin de détermin-
erie mécanisme de Ia diminution d'IMPF aprés 3 semaines de depletion
en K, des rats ont été traités en aigu avec de l'indomCthacine. II n'y
avait pas de modification significative d'IMPF chez les rats contrôles,
ou déplétés en K pendant 3 semaines après traitement par l'indométha-
cine. Ces rCsultats suggCrent que Ia reduction du contenu médullaire en
solutés apres 2 semaines de déplétion en K ne peut être attribuée a une
reduction d'IMPF. En outre, les produits des systèmes enzymatiques
de Ia cyclooxygenase ne paraissent pas contribuer de facon importante
a Ia reduction d'IMPF mesurée après 3 semaines de depletion alimen-
taire en K.
the defect caused by potassium (K) depletion has been ap-
proached from several viewpoints. The results of some of these
investigations have been reviewed elsewhere [4]. Despite the
continuing interest in elucidating the mechanism of the concen-
trating defect due to K-depletion, a significant degree of contro-
versy exists in major research areas. For example, although
there is evidence from in vitro experiments that the generation
of cyclic AMP in response to ADH is impaired in hypokalemic
animals [5, 6], results from in vivo experiments fail to show that
inner medullary collecting duct response to ADH is impaired in
hypokalemic hamsters [7] and rats [8]. If collecting duct re-
sponse to ADH is not impaired in K-depletion, then failure to
maintain adequate medullary solute could be the cause of
reduced urine osmolality. The reduction in medullary solute
content in K-depletion [3] could be due to failure to transport
adequate amounts of urea and sodium chloride into the intersti-
tium or dissipation of the gradient due to a change in inner
medullary plasma flow (IMPF) [9—11]. The finding that IMPF
was reduced in rats K-depleted for 21 days [12] was thought to
reflect a lower delivery of plasma to juxtamedullary nephrons
which may reduce solute delivery to the loop of Henle. In this
manner, the reduction in medullary solute content could be
explained, in whole or in part, by decreased perfusion of
juxtamedullary nephrons.
Dietary potassium deprivation produces a spectrum of time-
dependent changes in renal and systemic function. For exam-
ple, decreases in plasma K concentration and aldosterone
secretion, and increases in distal nephron K reabsorption,
occur within the first 3 days of K restriction [13], while
polydypsia and the renal concentrating defect occur approxi-
mately on days 7 and 14, respectively [14]. If the decrease in
IMPF in K-depleted rats is associated with the initiating factor
responsible for the development of the concentrating defect,
then this change in renal hemodynamics should be present after
only 2 weeks of K-depletion at which time the defect first
appears. It is the purpose of the present investigation to
determine if a change in 1MPF is associated with the appear-
ance of the renal concentrating defect in rats K-depleted for
only 14 days.
An impairment of urine concentrating ability associated with
hypokalemia in humans [1] and animals [2, 3] has been known
for over 20 years. Since the production of a maximally concen-
trated urine depends on extrarenal as well as renal mechanisms,
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Regarding the mechanism of the decrease in IMPF in rats K-
depleted for 3 to 4 weeks duration, there is evidence that
products of the cyclo-oxygenase enzyme system may affect
IMPF [9]. In addition, inner medullary production of the
vasoconstrictor, thromboxane A, has been shown to be in-
creased in tissue derived from K-depleted rats [15]. Therefore,
it is also the purpose of this study to examine the effect of
inhibition of the cyclo-oxygenase enzyme system on IMPF in
rats K-depleted for 3 to 4 weeks.
The results of the present study show: (1) IMPF is normal
after 2 weeks of K-depletion at a time when the renal concen-
trating defect is well established. (2) As the duration of K-
depletion continues, the renal concentrating defect does not
worsen, however, IMPF decreases confirming the previous
report by Whinnery and Kunau [121. (3) Treatment of rats K-
depleted for 3 to 4 weeks with indomethacin does not signifi-
cantly increase IMPF.
Methods
Experiments were performed on 69 male Munich-Wistar rats
(Timco Breeding Laboratories, Houston, Texas) weighing 170
4.2 g. Animals were fed a K-deficient diet (ICN Nutritional
Biochemical Division, International Chemical and Nuclear
Corp., Cleveland, Ohio) or a diet of normal K content [potassi-
um, 4 mM/kg diet, added to the K-deficient diet (ICN)]; both
were supplemented with magnesium. It is well established that
water intake increases and food intake decreases in animals
consuming a K-deficient diet. In a preliminary balance study,
food and water intakes were measured in rats consuming either
the control or K-deficient diet. Rats consumed approximately 6
g of K-deficient diet per 100 g of body weight per day. Control
rats drank approximately 20 ml/lOO g body weight per day.
Therefore, all rats were given and consumed only 6 g of diet per
100 g body weight per day; water intake in the rats consuming
the K-deficient diet was restricted to 20 ml/l00 g body weight
per day. Animals were subsequently divided into five experi-
mental groups: (I) Control rats (N = 17) consumed a measured
quantity of normal K diet as described above and drank tap
water. (2) Rats K-depleted 16 days (N = 19) consumed a
measured quantity of K-deficient diet and were given and
consumed 20 ml/l0O g body weight per day of distilled water for
14 to 17 days (m = 15.7 0.21). (3) Rats K-depleted 24 days (N
= 15) were treated the same as group 2 but were maintained on
this dietary regimen for 22 to 30 days (m = 24.3 1.09). (4)
Control rats given indomethacin (N = 9) were treated the same
as group I but received indomethacin on the day of the
experiment. (5) Rats K-depleted 24 days (N 9) were treated
the same as group 3, but received indomethacin on the day of
the experiment.
Maximum urine concentrating ability. After a minimum of 14
days on the control diet, and after 14 and 21 days of K
depletion, maximum urine concentration was measured in the
first urine sample collected following 15 hr of dehydration.
Animals were returned to their cages and allowed 24 to 48 hr
before any further experiments were performed.
Clearance experiments. GFR, CPAH, urine flow rate, and K-
excretion were measured in (6 to 11 animals per group) in
control and K-depleted rats (groups 1 to 5). Animals were
anesthetized by intraperitoneal injection of ketamine hydro-
chloride (Parke Davis and Co., Detroit, Michigan) 50 mg/kg and
mactin 20 mg/kg (Byk-Gulden, Konstanz, West Germany) and
placed on a thermostatically controlled table. A tracheostomy
was performed, A PE-lO catheter for the infusion of additional
anesthetic when needed and a PE-50 catheter were inserted into
the same jugular vein. The PE-50 catheter was used for the
infusion of inulin and 3H PAH containing solutions during the
clearance measurements and the subsequent infusion of 251
albumin for the measurement of IMPF. Another PE- 10 catheter
for the infusion of FD+C green dye number 3 (50 mg/mI,
Keystone Aniline and Chemical Co., Chicago, Illinois) for the
purpose of measuring renal transit time was inserted into the
other jugular vein. A suprapubic incision was made, the bladder
was externalized, and a PE-60 catheter with a flared end was
inserted. The left femoral artery was catheterized with a length
of PE-50 tubing for blood collection and continuous monitoring
of blood pressure (BP). Only data from animals with mean
arterial BP greater than 90 mm Hg throughout the experiment
were accepted.
As soon as the jugular catheters were inserted, the animal
was given I ml of 0.9% NaCI containing 3 pCi of 3H PAH and 10
mg of inulin as a priming dose and an infusion of the same
solution began at the rate of 1.5% body weight per hour. Plasma
levels of 3H PAH were maintained approximately 100 x back-
ground. Plasma levels of inulin were maintained between 20 to
50 mg/dl. Following a 30-mm equilibration period, urine sam-
ples were collected into a weighed tube for 30 mm. A blood
sample was taken at the beginning and the end of the urine
collection.
Inner medullary plasma flow. Studies were performed in
control and experimental animals immediately following the
inulin and PAH clearance experiments. In these animals inner
medullary plasma flow was measured by the '251-albumin
accumulation method initially described by Lilienfield, Masa-
zini, and Bauer 116] and later modified by Solez et al [17].
Following isolation of the kidneys and placement of silk liga-
tures (3-0) about the renal pedicle, a microscope was positioned
over the kidney to assist in determining the time of arrival of
1251-albumin. Before the infusion of '251-albumin was initiated,
the transit time of FD+C green was taken. If proximal transit
time was greater than 15 sec, the appearance of distal tubules
was greater than 45 sec or dye was retained in the tubules for
more than 2 mm, the experiment was terminated. The PE-50
catheter in the jugular vein was then attached to a syringe
containing 0.9% NaCI with 10 Ci/ml of '251-albumin (Mallin-
crodt, St. Louis, Missouri) colored with 25 mg/mI of FD+C
green dye on the infusion side of the reciprocal action pump
(Harvard Apparatus, Millis, Massachusetts). The femoral arte-
rial catheter was attached to the withdrawal side of the pump.
After the pump was started, timing of the perfusion began when
the dye reached the kidney. All perfusions were performed for
20 sec. Simultaneously, the pump was stopped, and the renal
ligatures were pulled tight. The kidneys were weighed after
excess blood was expressed and then using a microscope, the
entire inner medulla was removed as one piece. The inner
medulla was weighed and then counted along with 25tI of
arterial plasma collected during the perfusion period.
Treatment with indoinethacin, To determine if the decrease
in inner medullary plasma flow measured in rats K-depleted for
24 days was due to increased levels of vasoconstrictor products
of the cyclo-oxygenase enzyme system, control and long-term
Abbreviations and symbol: KW, kidney weight; BW,
The values refer to the extraction ratio of PAH.
b P < 0.01 compared to groups I and 4.
'P < 0.01 compared to group 1.
d P < 0.05 compared to group I.
P < 0.05 compared to group 4.
P < 0.01 compared to all groups.
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K-depleted rats (groups 4 and 5) were given an intraperitoneal
dose of indomethacin, 5 mg/kg. The rats were anesthetized as
described previously; indomethacin was added to the perfusion
to deliver 5 mg/kg/hr, and the clearances of inulin and PAH
were measured. Inner medullary plasma flow was measured as
described at least 1.5 to 2 hr after treatment with indomethacin
was initiated.
PAH extraction ratio and inner medullary tissue water. In
separate experiments, PAH extraction was measured in four to
nine animals per group from groups I to 5. Rats were anesthe-
tized with mactin and ketamine and catheters were inserted as
described previously. Thirty minutes after the initiation of the
intravenous infusion, the abdomen was opened by a midline
incision, and the left renal vein was exposed. Great care was
taken to maintain intra-abdominal temperature at 37°C. Tubular
transit time was measured and the experiment was terminated if
it was not within the range of normal. A sample of 0.1 ml of
renal venous blood was drawn by puncture of the vein with a
30-gauge needle, which was followed immediately by a collec-
tion of 0.1 ml of femoral arterial blood. Two to three such paired
collections of renal venous and arterial blood were made in
these studies. When blood sampling was completed, ligatures
which had been placed around the renal pedicles were pulled
tight, and the kidneys were removed and weighed as described.
The inner medulla was removed from each kidney and placed in
a pre-weighed vial. The wet weight was obtained with use of a
stainless steel hook. The tissue samples were dried to a
constant weight in a drying oven (90°C).
Analytical ,nethods. Urine osmolality was measured by a
Vapor Pressure Osmometer (Wescor Co., Ogden, Utah). Potas-
sium and sodium in urine and plasma were measured by flame
photometry (Model 143, Instrumentation Laboratories, Lexing-
ton, Massachusetts). To measure PAH clearance and extraction
ratio, radioactivity in aliquots of urine, arterial and venous
plasma were counted in a liquid scintillation counter (Searle
Delta 300, Searle Analytic, Inc., Chicago, Illinois). Samples
were corrected for quenching; clearance and extraction ratio of
PAH were calculated in a standard fashion. Measurement of
urine and plasma inulin concentration was performed with an
autoanalyzer (Technicon Instruments Corporation, Tarrytown,
New York), and the inulin clearance was calculated. 125I
albumin in plasma and inner medullary tissue samples were
measured with a gamma counter (Biogamma II, Beckman
Instruments, Inc., Irvine, California). Inner medullary plasma
flow rate in ml/min/l00 g inner medullary weight was calculated
using the formula:
IMPF = (cpm/ml/I00 g IM)/(cpm/ml plasma)
x (60 sec/min)/(perfusion time(s)
One-way analysis of variance and the Student-Newman-Keul
multiple comparison test were used to analyze the data. The
data are expressed as the mean I SEM.
Results
Table I summarizes body weight, plasma K concentration,
urine flow rate, K excretion rate, GFR, CPAH, and the
extraction ratio of PAH measured in control and K-depleted
rats in the absence (groups I to 3) and in the presence of
indomethacin (groups 4 to 5). There were no statistically
significant differences in body weight among the five groups
studied, although long-term K-depleted rats (24 days) tended to
weigh less due to failure to grow and some weight loss during
Table 1. The effect of the duration of dietary K-depletion on body weight, plasma [K], urinary K excretion, urine flow rate, GFR, CPAH, and
the extraction ratio of PAH
Treatment
BW
g
(KJp
msi
UK V
/.LMIminIg KW
V
1ijlminlg KW
GFR
ml/min/g KW
GFR
mlI,nin/lOO g BW
CpAH
mI/minig KW Ext PAW
Group 1
Control
190
(10)
4.5
(10)
0.482
(10)
3.9
(10)
1.04
(8)
0.87
(8)
2.71
(10)
0.78
(7)
Group 2
K-Depleted
I6days
192
(13)
2.3h
(II)
0.015°
(II)
3.6
(II)
0.53°'
(II)
0.60
(II)
l.2P'
(II)
0.81
(6)
Group 3
K-Depleted
24 days
147
(6)
l.7'
(6)
0.018'
(6)
5.2
(6)
0.52'
(6)
0.68
(6)
I.25'
(6)
0.75
(9)
Group 4
Control
+ Indo
180
(7)
4.0
(6)
0.465
(6)
4.2
(6)
1.02
(4)
0.82
(4)
3.00
(6)
0.73
(5)
GroupS
K-Depleted
+ Indo
171
(9)
NS
2.1°
(8)
0.011°
(7)
2.8
(7)
NS
0.59''
(8)
0.69
(8)
NS
l.35'
(7)
0.611
(4)
body weight; Indo, indomethacin; ( ). number of animals.
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Inner medullary plasma flow. Inner medullary plasma flow,
measured by the accumulation of 1251-albumin, was significant-
ly reduced in rats K-depleted for 24 days (group 1, 35.1 1.93)
versus group 3, 13.8 1.84 mI/min/IQO g of IM weight, (P <
0.01, Fig. 2). However, IMPF was similar to control values in
rats K-depleted for a duration of only 16 days (group 2, 32.8
1.52).
I * Todetermine if the reduction of IMPF in group 3 animals was
due to an increase in vasoconstrictor products of the renal
cyclo-oxygenase system, IMPF was measured in control and
o long-term K-depleted rats given indomethacin acutely (groups 4
and 5, respectively). Treatment of control rats with 5 mg/kg of
o indomethacin produced no changes in GFR or renal plasma
flow. There was a slight decrease in the extraction ratio of
PAH, however, the change was not significant. There was also
no change in IMPF in control rats treated with indomethacin
(group 1, 35.1 1.93 vs. group 4, 34.6 3.45 ml/min/l00 g IM
weight, Fig. 2). There was no change in GFR or the clearance of
PAH in long-term K-depleted rats given indomethacin. Howev-
er, the data indicate there was a 32% increase in renal plasma
K1D4e1çIet:d Ke1çIet:d flow in K-depleted rats given indomethacin (group 3, 1.67 vs.group 5, 2.20) since there was a significant decrease in the
extraction ratio of PAH in group 5 rats (group 3, 0.76 0.015
vs. group 5, 0.61 0.014, P < 0.01). Despite the apparent
increase in renal plasma flow, IMPF increased slightly, but the
increase did not achieve statistical significance when compared
to untreated long-term K-depleted rats (group 3, 13.8 1.84 vs.
group 5, 18.1 1.63, ml/min/l00 g IM). IMPF measured in
group 5 K-depleted rats remained significantly lower than either
control groups I or 4 (group 5 vs. group I, 35,1 1.93 and group
4, 34.6 3.44 ml/min/l00 g IM, P < 0.01, Fig. 2).
As reported by other investigators [18, 19], K-depleted rats
fail to increase body weight at the same rate as pair-fed control
rats, however, renal growth continues. These two factors taken
together lead to a significant increase in the ratio of total renal
mass in grams (kidney weight) to body weight (100 g body
weight). After 2 weeks on the K-deficient diet, the ratio of
kidney weight to body weight is increased by 35% compared to
control rats and increases further (65%) in animals maintained
on the diet for 24 days compared to control rats (Table 2). In the
K-depleted kidney, however, the ratio of inner medullary mass
to the mass of the kidney remains within normal limits (Table
2). The increase in renal mass is not due to fluid accumulation
but rather to a true increase in tissue dry weight as evidenced by
the significant reduction in tissue water of the inner medulla
measured in K-depleted rats (Table 2).
Discussion
The mechanisms underlying the renal concentrating defect
associated with K-depletion are still largely unclear. One factor
complicating the elucidation of this problem is that dietary K-
depletion produces a continuum of time-dependent changes in
systemic and renal function [13, 14, 20]. With respect to
changes in water metabolism, it has been shown that polydypsia
develops on approximately day 7 of K-depletion in the rat while
renal concentrating ability remains normal until about day 14
[141.
Medullary sodium chloride accumulation depends on ascend-
ing limb sodium chloride reabsorption. This process is limited
.
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Fig. 1. Development of a renal concentrating defect in potassium-
depleted rats. Maximum urine osmolality measured after 15 hr of
dehydration in rats K-depleted for 14 days (, N = 13), and 21 days (0,
N = 12). compared to control rats (•, N = 10). The asterisk indicates P
< 0.01 compared to control. Parentheses indicate the number of
animals.
Control
the course of the dietary treatment. As expected, plasma K
concentration was significantly lower in K-depleted rats, and
they excreted 96% less potassium than control rats. For the
purpose of comparison, GFR has been calculated per gram of
kidney weight and per 100 g of body weight. Although GFR
tended to be lower in K-depleted rats when expressed per 100 g
of body weight, there were no significant differences. However,
when expressed per gram of kidney weight, a substantial
decrease in GFR in the K-depleted animals becomes evident.
GFR is reduced by nearly 50% in all K-depleted groups. The
clearance of PAH was strikingly decreased in rats K-depleted
for 16 and 24 days to values less than 50% of control. The
extraction ratio of PAH was not altered by 16 or 24 days of K-
deficiency, but a statistically significant reduction was mea-
sured in long-term K-depleted animals treated with indometh-
acm (group 5). The data indicate that renal plasma flow is
significantly reduced in the K-depleted animals (groups 2, 3,
and 5). Estimated renal plasma flow in control and K-depleted
rats are: control, 3.46; K-depleted 16 days, 1.52; and K-
depleted 24 days; 1.66 mI/mm per gram kidney weight. The
filtration fractions calculated from the mean values of CPAH,
extraction ratio of PAH, and GFR are: control, 33.5%; K-
depleted 16 days, 34.6%; and K-depleted 24 days, 3 1.1%.
As illustrated in Figure 1, a significant urinary concentrating
defect developed in K-depleted rats within 14 days of dietary K
deprivation. Maximum urine concentration measured after 15
hr of water deprivation was reduced in 14-day K-depleted rats
(1937 76.0 mOsm/kgH,o) compared to control rats (2801
92.5 mOsm/kg,o) but was not further accentuated by the
continuation of K-deficiency for 21 days (1971 83.7
mOsm/kg,0).
Fig. 2. Changes in inner medullary plasma
flow due to the duration of potassium
depletion and treatment with indo,nethacin.
Numbers inside the bar equal the number of
measurements. The asterisk indicates P <
0.01 compared to groups 1, 2, and 4.
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by the amount of sodium chloride delivered to the transporting
segment. It is clear that GFR fixes the upper limit of total solute
delivery to the ioop. Decreases in GFR which are not offset by
equivalent reductions in proximal sodium chloride reabsorption
will decrease solute delivery to loops of Henle. To the extent
that sodium chloride reabsorption by the ascending limb is
reduced below the rate of solute removal via medullary blood
flow, reductions in medullary sodium chloride would be expect-
ed to occur. There is controversy regarding the effect of dietary
K depletion on GFR. Some [20—22] but not all [12, 23—25]
studies report that GFR is decreased in K-depleted humans and
animals. In the present investigation, GFR and CPAHhave been
calculated as ml/min/100 g body weight and as ml/min/g kidney
weight. GFR and CPAH when calculated per 100 g body weight
are not significantly reduced in K-depleted rats. However, the
same functions when calculated per gram of kidney weight are
severely reduced to nearly 50% of control in the K-depleted
rats. The reason for this difference relates to the disruption of
the normal relation between renal growth and body weight gain
in K-depletion. It has been previously reported that K-depletion
causes renal hypertrophy. Two studies have shown that within
15 days of consuming a K-free diet there is a doubling of renal
mass, but only a 5 to 10% difference in body weight compared
to pair-fed control rats [12, 18]. Biochemical studies reveal a net
increase in protein synthesis and evidence of hyperplasia as
well as hypertrophy [19]. As reported in the present study and
other studies [12, 18, 19], the increase in kidney size reflects a
true increase in renal mass, since tissue water content is not
increased in K-depleted kidneys. In addition, the increase in
mass is accompanied by a potential increase in filtering renal
tissue. GFR [26] and RBF [20] when calculated as ml/min/g
kidney weight have been shown to be severely reduced in the
enlarged kidneys of rats K-depleted for 14 days. In one study
[26], GFR was returned to normal values per gram of kidney
weight following acute restoration of total body K. RBF [20]
was acutely increased to normal values per gram kidney weight
in K-depleted rats treated with saralasin and indomethacin.
Therefore, the hypertrophied kidneys of K-depleted rats appear
to be capable of normal rates of glomerular filtration and renal
blood flow. If renal mass increases without a proportionate
increase in GFR, then solute delivery to loops of Henle will not
be adequate for the increase in tissue growth. Although all areas
Table 2. The effect of 2 and 3 weeks of K-depletion on inner
medullary water content and ratios of kidney weight to body weight
and inner medullary weight to kidney weight
Condition
of rats
Inner medullary
H20 content
% KW/BW" lM/KWC
Control 87.3
(16)
0.82
(10)
0.0357
0.00134
(14)
K-depleted 84.3d 1.1 l 0.0366
16 days
(18) (13)
0.00264
(16)
K-depleted 83.6" 1.36" 0.0419
24 days
(14)
101
(7)
0.0042
(12)
NS
The number of measurements is in parentheses.
"The values represent the ratio of the weight of two kidneys in grams
to 100 g of body weight.
The values represent the ratio of the weight of each inner medulla to
the weight of the same kidney in grams.
P < 0.01 compared to control rats.
P < 0.05 compared to control rats.
of the kidney grow in K-depletion, there is striking proliferation
of the outer medulla [27]. The reduction in GFR in kidneys
undergoing hypertrophy in K-depleted animals may be a major
contributing factor to diminished medullary solute content [3] in
this electrolyte disorder.
Since there is evidence that alterations in IMPF may have
important effects on renal concentrating ability [9—111; the
finding that IMPF was reduced in rats K-depleted for approxi-
mately 3 weeks was considered to be a factor contributing to the
presence of the renal concentrating defect [12]. In that study,
the reduction in IMPF was thought to reflect decreased plasma
delivery to juxtamedullary nephrons which may have reduced
solute delivery to the loop of Henle, If the reduction in IMPF in
long-term K-depleted rats is associated with the initiating factor
responsible for the development of the concentrating defect,
then this change should be present in rats K-depleted for only 2
weeks at which time the defect first appears. The results of the
present study show that after 2 weeks of K-depletion the
Control K-Depleted K-Depleted
16 Days 24 Days
40-
30
20
10
Control K-Depleted
+ 24 Days
Indo
Indo
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concentrating defect is well established, however IMPF mea-
sured by the '251-albumin accumulation method is not signifi-
cantly different compared to IMPF measured in control rats. In
addition, I have confirmed the previous finding [12] that IMPF
is significantly reduced in rats K-depleted for more than 21
days. The results derived from the present study support the
conclusion that the development of the renal concentrating
defect due to K-depletion does not depend on changes in IMPF.
More specifically, the reduction in medullary solute content [3]
and the presence of the renal concentrating defect after 2 weeks
of K-depletion cannot be attributed to a reduction in IMPF.
Although the reduction in IMPF measured in long-term K-
depleted rats is not necessary for the development of the renal
concentrating defect, the mechanism underlying this change is
of some interest. There is evidence that inner medullary synthe-
sis of the vasoconstrictor, thromboxane A2 (assessed by mea-
surement of thromboxane B2, its stable metabolite) is increased
in tissue derived from rats K-depleted for 3 weeks [151 while the
synthesis of PGE (a vasodilator in the rat) is not increased [IS,
201. Since products of the cyclo-oxygenase enzyme system may
exert effects on IMPF [9]; IMPF was measured in long-term K-
depleted rats treated with indomethacin. The effect of indo-
methacin in K-depleted rats should be the reduction of elevated
levels of the vasoconstrictor thromboxane A2. Additional evi-
dence supporting this view comes from the study by Linas and
Dickman [20] in which equivalent increases in renal blood flow
in K-depleted kidneys were obtained with indomethacin or
imidazole (a specific inhibitor of thromboxane synthesis). If
other products of the cyclo-oxygenase enzyme system had
major effects on renal hemodynamics in K-depletion, one would
not expect the effects of inhibiting the entire pathway to be
similar to the effects of inhibiting only a small portion of the
same pathway. With regard to the effect of inhibition of the
cyclo-oxygenase enzyme system on renal hemodynamics in the
present study there was a similar increase in RPF (32%)
estimated from the extraction ratio of PAll and the clearance of
PAH in long-term K-depleted rats. The decrease in the extrac-
tion ratio of PAH in the presence of indomethacin observed in
this group is consistent with an earlier report [28] that indo-
methacin is a substrate for the organic acid transport system.
The extraction ratio of PAH decreased slightly in control rats
treated with indomethacin, but the change was not statistically
significant. That indomethacin inhibits PAH transport more in
long-term K-depleted rats may be related to the relative de-
crease in cortical mass [27] which occurs after 3 to 4 weeks of
dietary K-depletion.
In contrast to the effect of indomethacin on RPF in long-term
K-depleted rats, the results of the present study show that
IMPF is not significantly increased after treatment with this
cyclo-oxygenase inhibitor. This finding appears to conflict with
a recent report by Takamitsu and Kunau [29]. In that study,
however, treatment with indomethacin was carried out for 3
days prior to measurement of IMPF. In addition, although
IMPF was slightly increased following treatment with indo-
methacin, values measured in K-depleted rats were still greatly
reduced compared to the control rats in that study. Therefore, it
appears that vasoconstrictor products of the cyclo-oxygenase
enzyme system do not play a major role in the reduction in
IMPF measured in long-term K-depleted rats. In addition, the
results of the present study show that the decrease in IMPF in
long-term K-depleted rats is not due to a disproportionate
increase in inner medullary size. In conclusion, the renal
concentrating defect which develops after 2 weeks of dietary K-
deprivation occurs independently of changes in IMPF and
therefore must be due to other factors. Recent results from our
laboratories [26] using a modified loop microperfusion tech-
nique in vivo, suggest that thick ascending limb transport is
significantly impaired after 2 weeks of K-depletion; the defect
in loop transport correlates with the decrease in plasma K
concentration in K-depleted rats and is reversed when K is
administered acutely. Impaired sodium chloride transport by
the thick ascending limb coupled with reduced solute delivery
to loops of Henle (estimated from the decrease in GFR) would
be expected to contribute in a major way to the development of
the concentrating defect in K-depletion.
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